Doç. Dr. Eren Arslan Davulcu

Doctor and researcher Bakırköy Dr. Sadi Konuk Eğitim ve Araştırma Hastanesi İstanbul
Leukemia, Myelogenous, Chronic, BCR-ABL PositiveLeukemia, Lymphocytic, Chronic, B-Cell
Open institution page
Suggest a correction

Is this your profile? Claim it and verify your details.

Claim profile

Person ↔ Disease

Which diseases does this doctor work on?

From source
  • Leukemia, Myelogenous, Chronic, BCR-ABL Positive 2 publications
    Source: OpenAlex / PubMed MeSHView publications
  • Leukemia, Lymphocytic, Chronic, B-Cell 2 publications

Trust

Where does this information come from?

The source is stated next to each piece of information. If you see something wrong, you can suggest a correction.

  • InstitutionBakırköy Dr. Sadi Konuk Eğitim ve Araştırma Hastanesisaglik.gov.trFrom source
  • Area of workLeukemia, Myelogenous, Chronic, BCR-ABL PositiveExtracted from 2 publications · Model version —From source
  • Publications45 publicationsOpenAlex, ORCID, Europe PMCFrom source
  • ORCID0000-0001-9262-2883ORCIDFrom source
  • Last synchronised5 November 2026 08:55https://bakirkoysadikonukeah.saglik.gov.tr/TR-1482136/doktorlarimiz.html#eren-arslan-davulcusaglik.gov.tr

Scientific work

Publications on Leukemia, Myelogenous, Chronic, BCR-ABL Positive

45 publications

  1. (PB2953) REAL-WORLD EFFICACY AND CARDIOVASCULAR SAFETY OF ACALABRUTINIB IN B-CELL MALIGNANCIES: A TURKISH MULTICENTER EXPERIENCE COMPARING FRONTLINE INITIATION VS. TRANSITION AFTER IBRUTINIB INTOLERANCE Topic: 06. Chronic lymphocytic leukemia and related disorders -Clinical

    2026

    DOI 10.13140/rg.2.2.20277.44000 Source: OpenAlex

  2. CLINICAL IMPACT OF ELTROMBOPAG-ASSOCIATED IRON CHELATION IN ADULTS WITH IMMUNE THROMBOCYTOPENIA: A MULTICENTER REAL-WORLD STUDY

    Mediterranean Journal of Hematology and Infectious Diseases, 2026

    DOI 10.4084/mjhid.2026.027 PMID 41821563 Open-access full textSource: ORCID

  3. The Outcomes of Newly Diagnosed Multiple Myeloma Patients With Concurrent or Previous Solid Tumor History

    Clinical Lymphoma Myeloma & Leukemia, 2025

    DOI 10.1016/j.clml.2025.10.006 PMID 41206323 Source: OpenAlex

  4. Successful Treatment with Romiplostim Following Eltrombopag-Induced Liver Injury in Primary Immune Thrombocytopenia

    Turkish journal of haematology : official journal of Turkish Society of Haematology, 2025

    DOI 10.4274/tjh.galenos.2025.2025.0209 PMID 40719053 Open-access full textSource: Europe PMC

  5. Posttransplant Lymphoproliferative Disease: A Case Confused with Tuberculosis

    Turkish Journal of Nephrology, 2025

    DOI 10.5152/turkjnephrol.2025.24808 Open-access full textSource: OpenAlex

  6. Real-Life Outcomes of Bosutinib in Patients with Chronic Myeloid Leukemia: A Multicenter Nationwide Study from Turkey

    Blood, 2024

    DOI 10.1182/blood-2024-193433 Open-access full textSource: OpenAlex

  7. Impact of CALR and JAK2V617F Mutations on Clinical Course and Disease Outcomes in Essential Thrombocythemia: A Multicenter Retrospective Study in Turkish Patients,Esansiyel Trombositemide CALR ve JAK2V617F Mutasyonlarının Klinik Seyir ve Hastalık Sonuçlarına Etkisi: Türk Hastalarda Geriye Dönük Çok Merkezli Çalışma

    Turkish Journal of Hematology, 2024

    DOI 10.4274/tjh.galenos.2024.2023.0430 PMID 38433449 10 citations (Europe PMC) Open-access full textSource: ORCID

  8. Treatment of anemia in myelofibrosis: focusing on novel therapeutic options

    Expert Opinion on Investigational Drugs, 2024

    DOI 10.1080/13543784.2023.2294324 PMID 38073183 5 citations (Europe PMC) Source: ORCID

  9. The assessment of health-related quality of life in patients with polycythemia vera

    Medicine, 2024

    DOI 10.1097/md.0000000000038814 PMID 39058813 3 citations (OpenAlex) Open-access full textSource: OpenAlex

  10. A Case of Myosin Heavy Chain 9-Related Disorder Following Splenectomy Due to Misdiagnosis of Idiopathic Thrombocytopenic Purpura

    Cureus, 2024

    DOI 10.7759/cureus.55064 PMID 38550428 Open-access full textSource: OpenAlex

View all 45 publications